Bio-Rad Laboratories | BIO - Assets


Bio-Rad Laboratories reported $9.79B in Assets for its fiscal quarter ending in March of 2026.





Assets Change Date
Abbott USD 110.43B 23.72B Mar/2026
Agilent USD 13.07B 252M Mar/2026
Becton, Dickinson and Co. USD 50.83B 4.01B Mar/2026
Bio Techne USD 2.55B 27.9M Mar/2026
Bio-Rad Laboratories USD 9.79B 786.5M Mar/2026
Bruker USD 6.13B 110.7M Mar/2026
Charles River Laboratories USD 7.73B 594.89M Mar/2026
Danaher USD 83.54B 80M Mar/2026
General Electric Aerospace USD 128.45B 1.72B Mar/2026
Illumina USD 6.56B 85M Mar/2026
IQVIA Holdings USD 29.68B 269M Mar/2026
Laboratory Of America USD 19.09B 694.4M Mar/2026
Merck USD 128.68B 8.18B Mar/2026
Mettler Toledo International USD 3.67B 43.73M Mar/2026
Myriad Genetics USD 673.7M 32.9M Mar/2026
OraSure Technologies USD 379.17M 24M Mar/2026
Pacific Biosciences Of California USD 782.36M 1.72M Mar/2026
Quest Diagnostics USD 16.67B 448M Mar/2026
Repligen USD 2.93B 18.93M Mar/2026
Revvity USD 12B 171.82M Mar/2026
Roche Holding CHF 100.7B 5.94B Dec/2025
Siemens EUR 167.97B 2.16B Mar/2026
Standard Biotools USD 639.11M 71.36M Mar/2026
Thermo Fisher Scientific USD 113.28B 2.94B Mar/2026
Tosoh JPY 1.41T 64.61B Mar/2026
Waters USD 24.53B 19.45B Mar/2026